Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 1, 1999

View Archived Issues

OraVax, Peptide Therapeutics and Pasteur Merieux Connaught announce agreements

Novel class of PAF antagonists presented by Searle

Phthalimide derivatives from JT selectively inhibit IL-5 and IgE production

Improved treatments for NIDDM in development at Dr. Reddy's and Reddy-Cheminor

Inhibitors of cGMP phosphodiesterases discovered at Bayer

Selective COX-2 inhibitors evaluated for antiinflammatory and analgesic effects at Grelan

Daiichi patents broad-spectrum antibacterial series

Otsuka discovers new platelet aggregation inhibitors and antithrombotic agents

Grant will help Copernicus develop novel targeted CF gene therapy

Neurobiological Technologies awarded SBIR grant for Xerecept development

Gensia Sicor establishes marketing agreement with Abbott

BioFocus and Pharmacia & Upjohn join forces in drug discovery

Phase III trial for angina treatment begins at international sites

Increased PKC activity activity and role for PKC-beta inhibitors in heart failure

FDA advisory committee recommends approval of Natrecor

Genentech and Schwarz enter collaboration for GH products

New herpes vaccine from Cel-Sci proves effective in protecting mice

CPMP recommends approval of Paxene for AIDS-related KS

First market introduction for new asthma treatment --Seretide Diskus

Genetix and Cordis to develop angiogenic gene therapy products for cardiovascular disease

Regulatory plans for gatifloxacin outlined by Kyorin

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...